共 39 条
- [1] Kumar SK, Rajkumar V, Kyle RA, Et al., Multiple myeloma, Nat Rev Dis Primers, 3, (2017)
- [2] van de Donk NWCJ, Pawlyn C, Yong KL., Multiple myeloma, Lancet, 397, 10272, pp. 410-427, (2021)
- [3] Kumar SK, Rajkumar SV, Dispenzieri A, Et al., Improved survival in multiple myeloma and the impact of novel therapies, Blood, 111, 5, pp. 2516-2520, (2008)
- [4] Palumbo A, Cavallo F, Gay F, Et al., Autologous transplantation and maintenance therapy in multiple myeloma, N Engl J Med, 371, 10, pp. 895-905, (2014)
- [5] Kumar SK, Dispenzieri A, Lacy MQ, Et al., Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients, Leukemia, 28, 5, pp. 1122-1128, (2014)
- [6] Kyle RA, Gertz MA, Witzig TE, Et al., Review of 1027 patients with newly diagnosed multiple myeloma, Mayo Clinic Proc, 78, 1, pp. 21-33, (2003)
- [7] Kyle RA, Rajkumar SV., Multiple myeloma, Blood, 111, 6, pp. 2962-2972, (2008)
- [8] Palumbo A, Anderson K., Multiple myeloma, N Engl J Med, 364, 11, pp. 1046-1060, (2011)
- [9] Rajkumar SV., Multiple myeloma: 2022 update on diagnosis, risk stratification, and management, Am J Hematol, 97, 8, pp. 1086-1107, (2022)
- [10] Greipp PR, San Miguel J, Durie BG, Et al., International staging system for multiple myeloma, J Clin Oncol, 23, 15, pp. 3412-3420, (2005)